{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:13:59Z","timestamp":1740118439761,"version":"3.37.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","bmn.com","clinicalkey.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.tips.2024.10.008","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T13:12:08Z","timestamp":1730898728000},"page":"1092-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RH5 antigenic landscape shapes vaccine and antibody development"],"prefix":"10.1016","volume":"45","author":[{"given":"Palak N.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-1337","authenticated-orcid":false,"given":"Niraj H.","family":"Tolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2024.10.008_bb0005","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1016\/j.cell.2024.06.015","article-title":"Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype","volume":"187","author":"Barrett","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.10.008_bb0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.medj.2021.03.014","article-title":"Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination","volume":"2","author":"Minassian","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.tips.2024.10.008_bb0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10606","article-title":"Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum","volume":"480","author":"Crosnier","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.10.008_bb0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-018-0779-6","article-title":"Structure of Plasmodium falciparum Rh5\u2013CyRPA\u2013Ripr invasion complex","volume":"565","author":"Wong","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.10.008_bb0025","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41564-022-01261-2","article-title":"PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum","volume":"7","author":"Scally","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tips.2024.10.008_bb0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-023-06856-1","article-title":"The PfRCR complex bridges malaria parasite and erythrocyte during invasion","volume":"625","author":"Farrell","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.10.008_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies","volume":"178","author":"Alanine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.10.008_bb0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","volume":"515","author":"Wright","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.10.008_bb0045","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1016\/j.cell.2024.06.037","article-title":"Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.10.008_bb0050","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41467-022-33336-3","article-title":"Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion","volume":"13","author":"Patel","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724002190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724002190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T16:06:47Z","timestamp":1733414807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614724002190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0165614724002190"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2024.10.008","relation":{},"ISSN":["0165-6147"],"issn-type":[{"type":"print","value":"0165-6147"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RH5 antigenic landscape shapes vaccine and antibody development","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2024.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}